600774 Hanshang Group
- 8.15
- +0.20+2.52%
Hanshang Group News
Dragon Tiger List丨Hanshang Group fell to a standstill today, and the famous Travel and Investment Management League owner sold 9.132,700 yuan
Hanshang Group fell to a standstill today. According to data from the Dragon Tiger List, the sales department seats on the list traded 62.2462 million yuan throughout the day, accounting for 20.94% of the total transaction amount for the day. Among them, the purchase amount was 264.948 million yuan, and the sale amount was 35.7514 million yuan, with a total net sale of 9.256,500 yuan. Specifically, well-known investors appeared on the Dragon Tiger List. Zhang Mengzhu and Huatai Securities headquarters sold 9.1327 million yuan and 8.4629 million yuan respectively; the Beijing Anzhenmen Securities Sales Department of Cathay Pacific Junan Securities and Cathay Pacific Junan Securities Headquarters each bought 8.3823 million yuan and 5.9122 million yuan.
Is Hanshang Group Co., Ltd.'s (SHSE:600774) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Most readers would already be aware that Hanshang Group's (SHSE:600774) stock increased significantly by 58% over the past three months. We wonder if and what role the company's financials play in t
Express News | Hanshang Group: The company is not currently engaged in stem cell therapy business
The concept of assisted reproduction soared across the board. Dajia Weikang rose more than 16%, Hanshang Group's straight-line rise hit a standstill, and Xiangxue Pharmaceutical and Yuexin Health followed suit.
The concept of assisted reproduction soared across the board. Dajia Weikang rose more than 16%, Hanshang Group's straight-line rise hit a standstill, and Xiangxue Pharmaceutical and Yuexin Health followed suit.
Express News | Hanshang Group: Court Rules the End of Oriental Pharmaceutical's Reorganization Plan
Hanshang Group (600774.SH) announced first-quarter results, net profit of 126.717 million yuan, a year-on-year decrease of 47.76%
Hanshang Group (600774.SH) released its report for the first quarter of 2024. The company achieved operating income of 3 during the reporting period...
Hanshang Group (600774.SH) announced its 2023 annual results. Net profit of 61.2064 million yuan decreased by 32.24% year on year
According to Zhitong Finance App, Hanshang Group (600774.SH) released its 2023 annual performance report. During the reporting period, the company achieved operating income of 1.39 billion yuan, an increase of 0.19%; net profit attributable to shareholders of listed companies was 61.2064 million yuan, a year-on-year decrease of 32.24%; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 376.931 million yuan, a year-on-year decrease of 15.67%; and basic earnings per share were 0.2075 yuan.
Hanshang Group (600774.SH): Received 17.88 million yuan in government subsidies
Gelonghui, April 22丨Hanshang Group (600774.SH) announced that the company and its affiliated enterprises received a total of 17,882,339.82 yuan in government subsidies between August 29, 2023 and the date of publication of this announcement. Among them, the income-related subsidy was RMB 15,902,339.82, accounting for 17.97% of the company's most recent audited net profit attributable to shareholders of the listed company; the asset-related subsidy was RMB 1,980,000.00, accounting for 0.12% of the company's most recent audited net assets.
Hanshang Group (600774.SH): No participation or use of AI
Gelonghui, March 27丨Hanshang Group (600774.SH) said on an interactive platform that the company is currently not participating in or using AI.
Hanshang Group (600774.SH): Currently does not produce or sell atropine related pharmaceutical products
Gelonghui, March 27丨Hanshang Group (600774.SH) said on an interactive platform that its holding subsidiary Chongqing Dikang Changjiang Pharmaceutical Co., Ltd. holds atropine-related drug approvals (Sinopharm H50020864, Sinopharm H50020865, Sinopharm H50020866), but currently does not produce or sell atropine related pharmaceutical products.
Hanshang Group Co., Ltd.'s (SHSE:600774) Biggest Owners Are Private Companies Who Got Richer After Stock Soared 23% Last Week
Key Insights The considerable ownership by private companies in Hanshang Group indicates that they collectively have a greater say in management and business strategy The top 3 shareholders own 59%
Express News | Hanshang Group: Some directors, supervisors and managers plan to increase their holdings by 5 million yuan to 7 million yuan
Earnings Working Against Hanshang Group Co., Ltd.'s (SHSE:600774) Share Price Following 26% Dive
The Hanshang Group Co., Ltd. (SHSE:600774) share price has fared very poorly over the last month, falling by a substantial 26%. The drop over the last 30 days has capped off a tough year for shareh
Express News | Hanshang Group: Appointment of Zhang Zhentao as Secretary of the Company's Board of Directors
Should Weakness in Hanshang Group Co., Ltd.'s (SHSE:600774) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
It is hard to get excited after looking at Hanshang Group's (SHSE:600774) recent performance, when its stock has declined 13% over the past week. But if you pay close attention, you might find that
Retail stocks declined, and ZTE Commercial hit a halt
Glonghui, January 16 | ZTE Commercial hit a halt, and Hanshang Group, Yimin Group, Shenzhen SEG, Shanghai 900, and Eurasia Group followed suit.
Meilleure Health Sells 661,408 Shares of Hanshang Group
Meilleure Health International Industry Group (HKG:2327) said it sold 661,408 shares of Hanshang Group (SHA: 600774) in the secondary market in October 2023, for roughly HK$6.7 million. Proceeds will
Merry Health International (02327) further sells 661,400 shares of Han Shang (600774.SH) shares
Merry Health International (02327) announced that from October 20 to 31, 2023, the Group will advance...
Hanshang Group (600774.SH)'s net profit for the third quarter was 206.685 million yuan, a year-on-year decrease of 10.06%
On October 27, Gelonghui Group (600774.SH) announced its report for the third quarter of 2023. In July-September 2023, operating income was 315 million yuan, a year-on-year decrease of 2.46%; net profit attributable to shareholders of listed companies was 206.685 million yuan, a year-on-year decrease of 10.06%; and net profit attributable to shareholders of listed companies after deducting non-recurring profits and losses - 9104,000 yuan.
Hanshang Group (600774.SH): The product has successfully landed in more than 10,000 public and private hospitals in China
Glonghui September 5 | At the September 5 performance briefing, Hanshang Group (600774.SH) said that in terms of sales, the company attaches great importance to sales achievement capabilities, carefully trains marketers, and has formed a sales elite team of more than 400 people, spread across 31 provinces, cities, and autonomous regions across the country, reaching various sales channels such as hospitals, retail pharmacies, primary medical institutions, clinics, and e-commerce platforms. By providing professional services, marketers accurately convey the company's product knowledge and advantages to the market. The products have successfully landed in more than 10,000 public and private hospitals in China; at the same time, they have accelerated the retail side and the channel layout of the three terminals, which has now been repeated
Analysis
Price Target
No Data
